SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-23-000072
Filing Date
2023-11-08
Accepted
2023-11-08 16:14:55
Documents
91
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20230930.htm   iXBRL 10-Q 1359870
2 EX-31.1 supn-20230930x10qxex311.htm EX-31.1 9657
3 EX-31.2 supn-20230930x10qxex312.htm EX-31.2 10018
4 EX-32.1 supn-20230930x10qxex321.htm EX-32.1 4903
5 EX-32.2 supn-20230930x10qxex322.htm EX-32.2 4924
11 supn-20230930_g1.jpg GRAPHIC 90482
  Complete submission text file 0001356576-23-000072.txt   7999782

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20230930.xsd EX-101.SCH 47919
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20230930_cal.xml EX-101.CAL 84960
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20230930_def.xml EX-101.DEF 265017
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20230930_lab.xml EX-101.LAB 710886
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20230930_pre.xml EX-101.PRE 477928
85 EXTRACTED XBRL INSTANCE DOCUMENT supn-20230930_htm.xml XML 1191240
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 231388038
SIC: 2834 Pharmaceutical Preparations